UK markets close in 2 hours 17 minutes

Asensus Surgical, Inc. (ASXC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.2410-0.0020 (-0.82%)
At close: 04:00PM EDT
0.2420 +0.00 (+0.41%)
Pre-market: 09:08AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,577
8,577
7,087
8,232
3,175
Cost of revenue
13,155
13,155
10,872
11,096
5,166
Gross profit
-4,578
-4,578
-3,785
-2,864
-1,991
Operating expenses
Research development
37,023
37,023
28,942
19,348
16,621
Selling general and administrative
36,076
36,076
34,928
32,718
27,201
Total operating expenses
73,552
73,552
71,578
63,320
54,623
Operating income or loss
-78,130
-78,130
-75,363
-66,184
-56,614
Interest expense
0
0
410
370
19
Total other income/expenses net
-1,542
-1,542
-611
3,727
-4,230
Income before tax
-78,119
-78,119
-75,243
-62,237
-60,828
Income tax expense
314
314
318
225
-1,516
Income from continuing operations
-78,433
-78,433
-75,561
-62,462
-59,312
Net income
-78,433
-78,433
-75,561
-62,462
-59,312
Net income available to common shareholders
-78,433
-78,433
-75,561
-62,462
-60,023
Basic EPS
-0.33
-
-0.32
-0.28
-0.85
Diluted EPS
-0.33
-
-0.32
-0.28
-0.85
Basic average shares
242,770
-
236,492
226,960
70,809
Diluted average shares
242,770
-
236,492
226,960
70,809